Target ALS
  • NEWS
  • DONATE
  • ABOUT US
    • CHALLENGE
    • OUR APPROACH
    • OUR IMPACT
    • ABOUT ALS
  • RESOURCES FOR SCIENTISTS
    • HUMAN POSTMORTEM TISSUE CORE
    • GENOMIC DATASETS
    • STEM CELL CORE
    • ANIMAL MODELS
    • IN VIVO TARGET VALIDATION CORE
    • VIRAL VECTOR CORE
    • ANTIBODY CORE
    • LONGITUDINAL BIOFLUIDS CORE
  • RESEARCH
    • FUNDED CONSORTIA
    • ANNUAL MEETING
    • PUBLICATIONS
  • FUNDING OPPORTUNITIES
  • COMMUNITY
    • FOUNDER
    • LEADERSHIP
    • SCIENTISTS
    • SPRINGBOARD FELLOWS
    • PARTNERS
  • TAKE ACTION
    • CONTACT US
    • EMAIL SIGN UP
    • DONATE NOW
    • WAYS TO GIVE
Select Page
Target ALS Announces New Corporate Council Partnership Opportunity

Target ALS Announces New Corporate Council Partnership Opportunity

by Brian | Jun 9, 2022 | News

Collaboration guides each step of our work, especially in how we fund promising ALS research. For that reason, the Target ALS Corporate Council was created to extend our partnerships across industries, with new perspectives. We are excited to announce this new...
n-Lorem Foundation and Columbia University Establish Silence ALS Initiative

n-Lorem Foundation and Columbia University Establish Silence ALS Initiative

by Melissa Rentfrow | May 3, 2022 | News

Silence ALS initiative will offer an integrated solution to identify, support and potentially treat nano-rare ALS patients. n-Lorem foundation and Columbia University receive a founding donation from Target ALS of $400,000 to formalize the Silence ALS initiative and...
Target ALS and Mitsubishi Tanabe Pharma America Announce Winner of the First Annual Rebecca Luker Courage Award

Target ALS and Mitsubishi Tanabe Pharma America Announce Winner of the First Annual Rebecca Luker Courage Award

by Melissa Rentfrow | Apr 28, 2022 | News

The organizations also praise an unsung hero and recognize groundbreakers including researchers, philanthropists, and patients Target ALS and Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced Merit E. Cudkowicz, Chief of the Neurology Department at...
Alzheimer’s Drug Discovery Foundation (ADDF) and Target ALS Announce Partnership to Accelerate Biomarker Discovery and Development

Alzheimer’s Drug Discovery Foundation (ADDF) and Target ALS Announce Partnership to Accelerate Biomarker Discovery and Development

by Steve Schonberg | Dec 21, 2021 | News

Collaboration, with Support from the ADDF’s Diagnostics Accelerator, Will Create Funding Opportunities to Advance Potential Biomarkers in Related Neurodegenerative Diseases. The Alzheimer’s Drug Discovery Foundation (ADDF) and Target ALS announced today a new...
Target ALS and Mitsubishi Tanabe Pharma America Announce Winner of the First Annual Rebecca Luker Courage Award

Target ALS and Mitsubishi Tanabe Pharma America Announce Rebecca Luker Courage Award Series and Call for Nominations

by Steve Schonberg | Jul 27, 2021 | News

Award Will Recognize Members of the ALS Community Who Embrace a Courageous Spirit Target ALS and Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the establishment of the inaugural Target ALS Rebecca Luker Courage Award. The award will spotlight...

  • Challenge
  • Contact
  • Our Approach
  • Resources For Scientists
  • Donate
  • Call For Proposals
  • Funded Consortia
  • Annual Meeting
  • Privacy Policy
  • Credits

FOLLOW US

  • Instagram
  • Facebook
  • Instagram
  • Twitter

Support Target ALS

When you shop at smile.amazon.com,
Amazon donates.
Go to smile.amazon.com

The Target ALS (TALS) website is intended for informational purposes only. Opinions expressed may not be that of TALS or its employees. For more information about our digital policies, click here.

AmazonSmile and the AmazonSmile logo are trademarks of Amazon.com, Inc. or its affiliates

© 2022 Target ALS Foundation, Inc.
Target ALS Foundation
P.O. Box 1598
New York, NY 10101
(332) 333-4140
Steck Insights WordPress Consulting